Cargando…

Type I error control in biomarker-stratified clinical trials

Detalles Bibliográficos
Autores principales:	Parashar, Deepak, Bowden, Jack, Starr, Colin, Wernisch, Lorenz, Mander, Adrian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4659228/ http://dx.doi.org/10.1186/1745-6215-16-S2-O84

Ejemplares similares

Adaptive enrichment in biomarker-stratified clinical trial design
por: Parashar, Deepak, et al.
Publicado: (2013)

An optimal stratified Simon two‐stage design
por: Parashar, Deepak, et al.
Publicado: (2016)

Designing a preliminary adaptive study to inform a biomarker trial in Psoriasis
por: Prevost, Andrew T, et al.
Publicado: (2011)

Stratified medicine in practice: review of predictive biomarkers in European Medicines Agency (EMA) indications
por: Malottki, Kinga, et al.
Publicado: (2011)

Stratified randomisation: a hidden form of clustering?
por: Kahan, Brennan C, et al.
Publicado: (2011)

Combining multiple predictive markers in stratified medicine
por: Emsley, Richard, et al.
Publicado: (2015)

Impact of lack-of-benefit stopping rules on treatment effect estimates of two-arm multi-stage (TAMS) trials with time to event outcome
por: Choodari-Oskooei, Babak, et al.
Publicado: (2013)

CMR to stratify post-TAVR paravalvular leak in patients with suboptimal echocardiography
por: Hartlage, Gregory, et al.
Publicado: (2014)

Who do treatments work for and why? Understanding treatment-effect mechanisms in stratified medicine
por: Emsley, Richard, et al.
Publicado: (2013)

Impaired thymic AIRE expression underlies autoantibodies against type I IFNs in humans with inborn errors of the alternative NF-κB pathway
por: Voyer, Tom Le, et al.
Publicado: (2023)

Adaptive dose-finding designs to identify multiple doses that achieve multiple response targets
por: Bond, Simon, et al.
Publicado: (2013)

Tau(i), A high-resolution metabolic imaging biomarker for myocardium
por: Springer, Charles S, et al.
Publicado: (2014)

An adaptive biomarker strategy clinical trial design
por: Wason, James, et al.
Publicado: (2013)

Inhibitors of human immunodeficiency virus type I
por: Hazuda, Daria J
Publicado: (2006)

Evaluating statistical characteristics of biomarker-guided trial designs
por: Antoniou, Miranta, et al.
Publicado: (2015)

Quantifying model errors using similarity to training data
por: Brown, Rob D, et al.
Publicado: (2010)

Errors in acute surgery: a statewide hospital survey
por: Dries, David J, et al.
Publicado: (2009)

Targeting activated T cells in type I diabetes and islet transplantation
por: Chatenoud, Lucienne
Publicado: (2011)

A toxicity-dependent feasibility bound for the escalation with overdose control approach in phase I cancer trials
por: Wheeler, Graham, et al.
Publicado: (2015)

O058 Awareness of errors is impaired by sleep restriction but not total sleep deprivation
por: Boardman, J, et al.
Publicado: (2022)

O039 Differential effects of sleep deprivation and sleep restriction on error awareness
por: Boardman, J, et al.
Publicado: (2021)

Reducing rigid-body error in a functional technique to determine ankle joint axes
por: Leitch, J, et al.
Publicado: (2008)

Technical error of vertebral rotation measurement directly on the computer screen, according to Raimondi method
por: Rigo, Manuel D, et al.
Publicado: (2010)

Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial.
por: Ahmed, Nabil, et al.
Publicado: (2015)

Test-retest standard error of measurements for full-torso surface topography parameters in healthy teenagers
por: Watkins, EM, et al.
Publicado: (2009)

Intratumoral electroporation of plasmid interleukin-12: efficacy and biomarker analyses from a phase 2 study in melanoma (OMS-I100)
por: Daud, Adil, et al.
Publicado: (2015)

An adaptive trial design for updating the threshold of a continuous biomarker
por: Spencer, Amy, et al.
Publicado: (2015)

Partial inhibition of HIV replication by type-I interferons: impact of cell-to-cell viral transfer
por: Vendrame, Daniela, et al.
Publicado: (2009)

Wish list: which biomarker studies in HAM/TSP should be funded by the God of all trial funds?
por: Yamano, Yoshihisa
Publicado: (2014)

A survey of facilitators and barriers to recruitment to the magnetic trial
por: Kaur, Geetinder, et al.
Publicado: (2013)

MRI-guided transurethral ultrasound prostate ablation: midterm outcomes of a phase I clinical trial
por: Burtnyk, Mathieu, et al.
Publicado: (2015)

Tapering of the cervical spinal canal in patients with distended or non-distended syringes secondary to Chiari malformation type I
por: Zhu, Zezhang, et al.
Publicado: (2015)

Tracing cellular sources of pathogenic type I-interferon in the TREX1(-/-) mouse model of lupus like-disease
por: Peschke, K, et al.
Publicado: (2015)

A Bayesian dose-finding procedure applied to a seamless phase I/II trial in rheumatoid arthritis
por: Whitehead, Anne, et al.
Publicado: (2011)

Sputum interleukin (IL)-13 as a biomarker for the evaluation of asthma control
por: Tsilogianni, Zoi, et al.
Publicado: (2015)

Lipidomics in biomarker development
por: Wenk, Markus
Publicado: (2010)

P431 Tip to correct the variation position error in applying long-read high-throughput sequencing technology for fungal identification
por: Langsiri, Nattapong, et al.
Publicado: (2022)

O073 The Relationship between Circadian type and Physical Activity on Cognitive Performance during Simulated Nightshifts: A Randomised Controlled Trial.
por: Easton, D, et al.
Publicado: (2023)

Evidence across CMR sites and systems of background velocity offset errors requiring correction before accurate measurement of regurgitant and shunt flow
por: Gatehouse, Peter D, et al.
Publicado: (2009)

HIV control through a single nucleotide on the HLA-I locus
por: Kløverpris, H, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_5477vle9ob322lqkk8dvcvi4qc